Lucid Diagnostics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	45	63	53	198
Market Cap Growth	-35.68%	18.41%	-73.09%	-
Enterprise Value	34	59	33	144
PE Ratio	-	-1.20	-0.95	-7.04
PS Ratio	14.99	25.94	141.08	395.33
PB Ratio	3.76	-27.25	2.31	3.61
P/FCF Ratio	-1.01	-1.91	-1.74	-10.67
P/OCF Ratio	-1.02	-1.92	-1.79	-11.19
EV/Sales Ratio	11.44	24.44	86.77	288.01
EV/EBITDA Ratio	-0.64	-1.19	-0.60	-5.25
EV/EBIT Ratio	-0.61	-1.14	-0.58	-5.25
EV/FCF Ratio	-0.74	-1.80	-1.07	-7.77
Debt / Equity Ratio	1.19	-6.60	0.09	-
Debt / EBITDA Ratio	-0.32	-0.31	-0.04	-
Debt / FCF Ratio	-0.37	-0.46	-0.07	-
Quick Ratio	1.24	0.64	2.67	12.64
Current Ratio	1.38	0.75	2.89	13.45
Asset Turnover	0.09	0.06	0.01	0.02
Interest Coverage	-118.07	-125.60	-7020.37	-41.61
Return on Equity (ROE)	-801.60%	-523.80%	-168.50%	-136.20%
Return on Assets (ROA)	-161.50%	-138.50%	-126.00%	-91.80%
Return on Capital (ROIC)	-172.43%	-374.55%	-224.59%	-50.09%
Earnings Yield	-121.95%	-83.62%	-105.61%	-14.21%
FCF Yield	-86.38%	-52.46%	-57.52%	-9.37%
Buyback Yield / Dilution	-9.87%	-15.44%	-94.44%	-31.81%
Total Shareholder Return	-9.87%	-15.44%	-94.44%	-31.81%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).